Skip to content

Media Release, September 30, 2010


Alliance to Focus on Funding Bill that Congress Will Consider After Election Day

WASHINGTON, D.C., September 30, 2010 – The Alliance for a Stronger FDA today expressed concern that the new FY 11 Continuing Resolution (CR) provides no additional funding for the US Food and Drug Administration (FDA). The CR funds the federal government through December 3, 2010. The Alliance committed to pressing Congress to add funds when it considers the next CR after Election Day.

“Every American relies on the FDA for safe foods and safe and effective medical product. Flat-funding for even two months will have immediate consequences on the ability of FDA to sustain and build capacity in the areas of growing public need.” said Wayne Pines, President of the Alliance. “The Alliance and its members will be putting all of our efforts into getting additional funds for FDA when Congress reconvenes in November.”

Before adjourning until after Election Day, the Senate and the House passed HR 3081, containing the Continuing Resolution for Fiscal Year 2011. Once the President signs the bill, the federal government will have monies to continue its activities from October 1 to December 3.

“For FDA, this could mean a slowing of its efforts to provide for adequate food inspectors and reviewers looking at the safety and efficacy of innovative medical products,” said Nancy Myers, Vice President of the Alliance. “The headlines over the last several months, such as the massive recall of contaminated eggs, make clear we need to continue to support improved funding levels for the agency.”

She added: “If the agency is put in a situation that it cannot adequately meet modern day regulatory challenges in a timely manner, it may have both health consequences and cause unnecessary job losses here in the US.”

“Congress opted for a uniform funding policy of no increases for any federal agencies. There was no consideration of federal priorities or the impact on mission-critical public health agencies,” said Troy Zimmerman, Vice President for Government Relations at the National Kidney Foundation. “We expect FDA’s growing responsibilities to be part of the dialogue when Congress considers the next CR.”

The Alliance for a Stronger FDA is a coalition of more than 180 consumer, patient, professional and research groups, companies, trade associations, and individuals who support increased appropriated funding for FDA. The Alliance is the only multi-stakeholder group that advocates for increasing resources at FDA to match the agency’s responsibilities.

If you wish to receive more information about the FY 2011 and FY 2012 appropriations cycles and why FDA needs increased funding, please send an e-mail to

More information about the Alliance and our positions can be found at: